Table 2 Association between resistin and mortality. The effect of resistin was adjusted in eleven models for each type of mortality. The models included age and sex, plus one of the exposure factors, and they were summarized with the HR (95% CI) among resistin categories.

From: Resistin as a risk factor for all-cause (and cardiovascular) death in the general population

Exposure factors

Oncological deaths

HR (95% CI)

Cardiovascular deaths

HR (95% CI)

Deaths from other causes

HR (95% CI)

All-cause deaths

HR (95% CI)

Resistin (BMI) Q2 vs Q1

1.04 (0.68–1.61)

1.20 (0.65–2.21)

1.22 (0.76–1.95)

1.13 (0.86–1.51)

Q3 vs Q1

1.05 (0.68–1.65)

1.28 (0.68–2.42)

0.87 (0.51–150)

1.03 (0.76–1.40)

Q4 vs Q1

0.93 (0.59–1.48)

2.03 (1.18–3.50)

0.94 (0.56–1.57)

1.15 (0.86–1.54)

Q5 vs Q1

1.59 (1.05–2.40)

1.87 (1.04–3.36)

1.48 (0.92–2.39)

1.61 (1.22–2.12)

Resistin (Phys Act) Q2 vs Q1

1.09 (0.71–1.67)

1.19 (0.65–2.20)

1.23 (0.77–1.97)

1.16 (0.88–1.54)

Q3 vs Q1

1.07 (0.68–1.68)

1.29 (0.68–2.42)

0.94 (0.55–1.61)

1.07 (0.79–1.45)

Q4 vs Q1

0.95 (0.60–1.50)

2.02 (1.17–3.49)

0.97 (0.58–1.63)

1.17 (0.88–1.57)

Q5 vs Q1

1.68 (1.11–2.53)

1.85 (1.03–3.33)

1.55 (0.96–2.50)

1.68 (1.27–2.21)

Resistin (HDL) Q2 vs Q1

1.05 (0.68–1.62)

1.18 (0.64–2.18)

1.20 (0.75–1.92)

1.13 (0.85–1.5)

Q3 vs Q1

1.06 (0.67–1.66)

1.28 (0.68–2.42)

0.94 (0.55–1.60)

1.06 (0.78–1.44)

Q4 vs Q1

0.94 (0.60–1.49)

1.93 (1.12–3.35)

0.96 (0.57–162)

1.15 (0.86–1.54)

Q5 vs Q1

1.60 (1.06–2.41)

1.82 (1.01–3.29)

1.47 (0.91–2.37)

1.60 (1.22–2.11)

Resistin (Dyslipidemia) Q2 vs Q1

1.04 (0.67–1.61)

1.25 (0.68–2.31)

1.23 (0.77–1.96)

1.15 (0.86–1.53)

Q3 vs Q1

1.09 (0.69–1.72)

1.36 (0.72–2.57)

0.91 (0.53–1.56)

1.08 (0.80–1.47)

Q4 vs Q1

0.98 (0.62–1.56)

2.08 (1.21–3.58)

0.98 (0.59–1.65)

1.21 (0.91–1.61)

Q5 vs Q1

1.65 (1.09–2.50)

1.92 (1.07–3.46)

1.47 (0.91–2.38)

1.65 (1.25–2.17)

Resistin (Medit Diet) Q2 vs Q1

1.08 (0.70–1.66)

1.22 (0.66–2.24)

1.22 (0.76–1.95)

1.15 (0.87–1.53)

Q3 vs Q1

1.06 (0.68–1.67)

1.30 (0.69–2.46)

0.96 (0.56–1.65)

1.08 (0.80–1.46)

Q4 vs Q1

0.96 (0.61–1.52)

1.92 (1.12–3.32)

0.97 (0.58–1.63)

1.17 (0.88–1.56)

Q5 vs Q1

1.62 (1.08–2.45)

1.84 (1.02–3.32)

1.53 (0.95–2.47)

1.63 (1.24–2.15)

Resistin (Alcohol) Q2 vs Q1

1.07 (0.70–1.66)

1.23 (0.65–2.30)

1.20 (0.74–1.93)

1.15 (0.86–1.53)

Q3 vs Q1

1.07 (0.68–1.68)

1.30 (0.68–2.46)

0.90 (0.52–1.55)

1.06 (0.78–1.44)

Q4 vs Q1

0.96 (0.60–1.51)

2.10 (1.21–3.64)

0.97 (0.58–1.64)

1.19 (0.89–1.59)

Q5 vs Q1

1.66 (1.10–2.51)

1.96 (1.08–3.55)

1.43 (0.88–2.32)

1.64 (1.24–2.16)

Resistin (Social Class) Q2 vs Q1

1.10 (0.70–1.72)

1.20 (0.64–2.26)

1.10 (0.67–1.80)

1.12 (0.84–1.50)

Q3 vs Q1

1.10 (0.69–1.76)

1.30 (0.68–2.52)

0.95 (0.55–1.64)

1.09 (0.80–1.49)

Q4 vs Q1

0.99 (0.62–1.60)

2.09 (1.18–3.70)

1.01 (0.59–1.72)

1.21 (0.90–1.64)

Q5 vs Q1

1.67 (1.08–2.56)

1.87 (1.01–3.46)

1.43 (0.87–2.36)

1.63 (1.22–2.17)

Resistin (Smoking) Q2 vs Q1

1.06 (0.69–1.64)

1.18 (0.64–2.17)

1.22 (0.76–1.95)

1.142 (0.86–1.51)

Q3 vs Q1

1.05 (0.67–1.65)

1.27 (0.67–2.39)

0.89 (0.52–1.54)

1.04 (0.77–1.41)

Q4 vs Q1

0.90 (0.57–1.43)

1.94 (1.12–3.34)

0.94 (0.56–1.58)

1.13 (0.84–1.50)

Q5 vs Q1

1.55 (1.03–2.35)

1.80 (1.00–3.25)

1.38 (0.84–2.24)

1.55 (1.17–2.05)

Resistin (Hypertension) Q2 vs Q1

1.02 (0.66–1.58)

1.21 (0.66–2.22)

1.23 (0.77–1.97)

1.13 (0.85–1.50)

Q3 vs Q1

1.04 (0.66–1.64)

1.30 (0.69–2.46)

0.91 (0.53–1.57)

1.05 (0.77–1.42)

Q4 vs Q1

0.96 (0.61–1.52)

2.04 (1.18–3.53)

0.99 (0.59–1.66)

1.18 (0.89–1.58)

Q5 vs Q1

1.63 (1.08–2.46)

1.90 (1.06–3.42)

1.53 (0.95–2.47)

1.65 (1.26–2.18)

Resistin (Diabetes) Q2 vs Q1

1.10 (0.71–1.69)

NA

1.28 (0.80–2.04)

1.20 (0.91–1.60)

Q3 vs Q1

1.06 (0.68–1.67)

NA

0.93 (0.54–1.58)

1.06 (0.78–1.43)

Q4 vs Q1

0.98 (0.62–1.56)

NA

1.03 (0.61–1.74)

1.249 (0.94–1.67)

Q5 vs Q1

1.67 (1.11–2.52)

NA

1.54 (0.96–2.49)

1.68 (1.28–2.21)

Resistin (ACS) Q2 vs Q1

1.08 (0.70–1.66)

1.11 (0.60–2.05)

1.21 (0.75–1.93)

1.13 (0.85–1.50)

Q3 vs Q1

1.08 (0.69–1.69)

1.15 (0.61–2.16)

0.93 (0.55–1.59)

1.05 (0.78–1.42)

Q4 vs Q1

0.96 (0.61–1.52)

1.96 (1.14–3.38)

0.98 (0.58–1.64)

1.18 (0.88–1.57)

Q5 vs Q1

1.67 (1.11–2.52)

1.64 (0.91–2.95)

1.49 (0.92–2.41)

1.61 (1.22–2.12)

  1. ACS Acute coronary syndrome, NA Not applicable.
  2. Significant values are in bold.